RNLXY
Renalytix Plc
Price Chart
Latest Quote
$1.19
| Previous Close | $1.19 |
| Open | $1.11 |
| Day High | $1.11 |
| Day Low | $1.11 |
| Volume | 4 |
Stock Information
| Shares Outstanding | 218.51M |
| Total Debt | $5.80M |
| Cash Equivalents | $6.20M |
| Revenue | $3.30M |
| Net Income | $-19.90M |
| Market Cap | $260.90M |
| EPS (TTM) | $-3.50 |
| Exchange | OQB |
đ Comprehensive Analysis
Company Data
| Enterprise Value | $10.04M |
| Sales | $3.30M |
| Income | $-19.90M |
| Book/sh | $-0.15 |
| Cash/sh | $0.03 |
| Employees | 46 |
Financial Ratios
| Quick Ratio | 1.39 |
| Current Ratio | 1.57 |
Returns & Margins
| Gross Margin | 45.46% |
| Operating Margin | -437.50% |
Ownership
| Insider Ownership | 1.07% |
| Insider & Institutional transactions data not available | |
Valuation Ratios
| Forward P/E | -6.28 |
| P/S | 79.06 |
| P/B | -7.96 |
Analyst Data
| Recommendation | none |
Technical Indicators
| SMA20 | $1.25 |
| SMA50 | $1.28 |
| SMA200 | $51.42 |
| RSI | 46.48 |
| ATR | 0.1105 |
| Shares Float | 7.28M |
| Volatility | 1.81 |
| Rel Volume | 0.16 |
Performance History
| Week | -0.91% |
| Month | -1.32% |
| Quarter | -42.32% |
| 6 Months | -98.91% |
| YTD | -70.08% |
| Year | -98.94% |
| 3 Years | -99.91% |
| 5 Years | -99.99% |
| 10 Years | -99.99% |
Sign up for free to view detailed scoring breakdown â premium is free during our trial period!
Recent Price History
| Date | Close | Volume |
|---|---|---|
| 2026-06-15 | $1.19 | 500 |
| 2026-06-12 | $1.25 | 400 |
| 2026-06-11 | $1.19 | 3,100 |
| 2026-06-10 | $1.28 | 1,000 |
| 2026-06-09 | $1.23 | 300 |
| 2026-06-08 | $1.21 | 0 |
| 2026-06-05 | $1.21 | 600 |
| 2026-06-04 | $1.30 | 200 |
| 2026-06-03 | $1.35 | 2,000 |
| 2026-06-02 | $1.23 | 12,500 |
| 2026-06-01 | $1.29 | 1,400 |
| 2026-05-29 | $1.33 | 700 |
| 2026-05-28 | $1.29 | 16,900 |
| 2026-05-27 | $1.22 | 4,700 |
| 2026-05-26 | $1.25 | 1,300 |
| 2026-05-22 | $1.18 | 1,700 |
| 2026-05-21 | $1.26 | 2,100 |
| 2026-05-20 | $1.20 | 2,100 |
| 2026-05-19 | $1.22 | 2,600 |
| 2026-05-18 | $1.23 | 8,000 |
About Renalytix Plc
Renalytix Plc develops artificial intelligence-enabled in vitro diagnostic solutions for clinical management of kidney diseases in Europe and the United States. It offers KidneyIntelX, a diagnostic platform that employs an artificial intelligence-enabled algorithm that combines various data inputs, including validated blood-based biomarkers, inherited genetics, and personalized patient data from electronic health record systems to generate a unique patient risk score. The company's products are used in kidney disease diagnosis and prognosis, clinical care, patient stratification for drug clinical trials, and drug target discovery. It has a license agreement with Mount Sinai Health System to develop and commercialize its products in connection with the application of artificial intelligence for the diagnosis of kidney disease. The company was formerly known as Renalytix AI plc and changed its name to Renalytix Plc in June 2021. The company was incorporated in 2018 and is based in London, the United Kingdom.
Income Statement (Annual)
| Metric | 2025-06-30 | 2024-06-30 | 2023-06-30 | 2022-06-30 |
|---|---|---|---|---|
| Revenue | ||||
| Reconciled Cost Of Revenue | $1,800,000 | $2,100,000 | $2,683,000 | $2,096,000 |
| Cost Of Revenue | $1,800,000 | $2,100,000 | $2,683,000 | $2,096,000 |
| Total Revenue | $3,000,000 | $2,300,000 | $3,403,000 | $2,970,000 |
| Operating Revenue | $3,000,000 | $2,300,000 | $3,403,000 | $2,970,000 |
| Expenses | ||||
| Interest Expense | $500,000 | $0 | - | $2,000 |
| Total Expenses | $20,200,000 | $32,800,000 | $45,624,000 | $56,153,000 |
| Rent Expense Supplemental | $400,000 | $300,000 | - | - |
| Net Non Operating Interest Income Expense | $-400,000 | $-400,000 | - | $-40,000 |
| Total Other Finance Cost | $-100,000 | $600,000 | - | $50,000 |
| Interest Expense Non Operating | $500,000 | $0 | - | $2,000 |
| Operating Expense | $18,400,000 | $30,700,000 | $42,941,000 | $54,057,000 |
| Selling And Marketing Expense | $400,000 | $700,000 | - | - |
| General And Administrative Expense | $4,900,000 | $10,800,000 | $28,662,000 | $39,524,000 |
| Other Non Operating Income Expenses | - | $249,000 | $656,000 | $131,000 |
| Other Operating Expenses | - | - | - | $10,313,000 |
| Income & Earnings | ||||
| Net Income From Continuing Operation Net Minority Interest | $-20,400,000 | $-45,500,000 | $-45,607,000 | $-45,276,000 |
| Net Interest Income | $-400,000 | $-400,000 | - | $-40,000 |
| Interest Income | $0 | $200,000 | - | $12,000 |
| Normalized Income | $-16,188,991 | $-30,700,000 | $-41,218,000 | $-43,735,380 |
| Net Income From Continuing And Discontinued Operation | $-20,400,000 | $-45,500,000 | $-45,607,000 | $-45,276,000 |
| Total Operating Income As Reported | $-17,200,000 | $-30,500,000 | $-42,221,000 | $-53,183,000 |
| Net Income Common Stockholders | $-20,400,000 | $-45,500,000 | $-45,607,000 | $-45,276,000 |
| Net Income | $-20,400,000 | $-45,500,000 | $-45,607,000 | $-45,276,000 |
| Net Income Including Noncontrolling Interests | $-20,400,000 | $-45,500,000 | $-45,607,000 | $-45,276,000 |
| Net Income Continuous Operations | $-20,400,000 | $-45,500,000 | $-45,607,000 | $-45,276,000 |
| Pretax Income | $-21,800,000 | $-45,500,000 | $-45,605,000 | $-45,251,000 |
| Special Income Charges | $-3,500,000 | $-10,500,000 | $0 | $0 |
| Interest Income Non Operating | $0 | $200,000 | - | $12,000 |
| Operating Income | $-17,200,000 | $-30,500,000 | $-42,221,000 | $-53,183,000 |
| Depreciation And Amortization In Income Statement | $0 | $2,000,000 | - | $2,254,000 |
| Depreciation Income Statement | $0 | $2,000,000 | - | $2,254,000 |
| Gross Profit | $1,200,000 | $200,000 | $720,000 | $874,000 |
| Per Share | ||||
| Diluted EPS | - | $-15.50 | $-28.00 | $-41.00 |
| Basic EPS | - | $-15.50 | $-28.00 | $-39.00 |
| Other | ||||
| Tax Effect Of Unusual Items | $-288,991 | $0 | $0 | $-361,380 |
| Tax Rate For Calcs | $0 | $0 | $0 | $0 |
| Normalized EBITDA (Bullshit earnings) | $-16,800,000 | $-28,200,000 | $-37,324,000 | $-50,792,000 |
| Total Unusual Items | $-4,500,000 | $-14,800,000 | $-4,389,000 | $-1,902,000 |
| Total Unusual Items Excluding Goodwill | $-4,500,000 | $-14,800,000 | $-4,389,000 | $-1,902,000 |
| Reconciled Depreciation | $0 | $2,500,000 | $508,000 | $489,000 |
| EBITDA (Bullshit earnings) | $-21,300,000 | $-43,000,000 | $-41,713,000 | $-52,694,000 |
| EBIT | $-21,300,000 | $-45,500,000 | $-42,221,000 | $-53,183,000 |
| Diluted NI Availto Com Stockholders | $-20,400,000 | $-45,500,000 | $-45,607,000 | $-45,276,000 |
| Otherunder Preferred Stock Dividend | $0 | $0 | $0 | $0 |
| Tax Provision | $-1,400,000 | $0 | $2,000 | $25,000 |
| Other Special Charges | $3,500,000 | - | - | $-115,000 |
| Impairment Of Capital Assets | $0 | $10,500,000 | $0 | - |
| Research And Development | $900,000 | $5,100,000 | $14,298,000 | $14,648,000 |
| Selling General And Administration | $5,300,000 | $11,500,000 | $28,662,000 | $39,524,000 |
| Diluted Average Shares | - | $2,163,587 | $1,644,201 | $1,457,225 |
| Basic Average Shares | - | $2,163,587 | $1,644,201 | $1,457,225 |
| Minority Interests | - | - | - | $0 |
| Write Off | - | - | - | $0 |
Balance Sheet (Annual)
| Metric | 2025-06-30 | 2024-06-30 | 2023-06-30 | 2022-06-30 |
|---|---|---|---|---|
| Assets | ||||
| Net Tangible Assets | $-7,000,000 | $-9,000,000 | $6,967,000 | $30,607,000 |
| Total Assets | $6,100,000 | $7,100,000 | $30,629,000 | $50,065,000 |
| Total Non Current Assets | $300,000 | $300,000 | $3,747,000 | $5,311,000 |
| Other Non Current Assets | $100,000 | $100,000 | $1,101,000 | $1,189,000 |
| Goodwill And Other Intangible Assets | $0 | $0 | - | $14,020,000 |
| Current Assets | $5,800,000 | $6,800,000 | $26,882,000 | $44,754,000 |
| Other Current Assets | $100,000 | $100,000 | $1,424,000 | $2,445,000 |
| Prepaid Assets | $600,000 | $300,000 | - | $1,257,000 |
| Inventory | $200,000 | $300,000 | - | $1,160,000 |
| Taxes Receivable | $600,000 | $0 | - | - |
| Accounts Receivable | $600,000 | $700,000 | $776,000 | $901,000 |
| Cash Cash Equivalents And Short Term Investments | $3,700,000 | $5,400,000 | $24,682,000 | $41,333,000 |
| Cash And Cash Equivalents | $3,600,000 | $4,700,000 | $24,682,000 | $41,333,000 |
| Cash Financial | $3,600,000 | $4,700,000 | $24,682,000 | $41,333,000 |
| Investmentin Financial Assets | - | $698,000 | $1,460,000 | $2,744,000 |
| Allowance For Doubtful Accounts Receivable | - | $-100,000 | $-100,000 | - |
| Gross Accounts Receivable | - | $822,000 | $876,000 | $901,000 |
| Non Current Deferred Taxes Assets | - | - | - | $0 |
| Other Intangible Assets | - | - | - | $14,020,000 |
| Current Deferred Assets | - | - | - | $36,000 |
| Other Receivables | - | - | - | $75,000 |
| Assets Held For Sale Current | - | - | - | - |
| Debt | ||||
| Net Debt | $4,700,000 | $3,800,000 | - | - |
| Total Debt | $8,300,000 | $8,500,000 | $12,119,000 | $12,342,000 |
| Long Term Debt And Capital Lease Obligation | $8,300,000 | $4,300,000 | $7,526,000 | $7,682,000 |
| Long Term Debt | $8,300,000 | $4,300,000 | $7,485,000 | $7,682,000 |
| Current Debt And Capital Lease Obligation | $0 | $4,200,000 | $4,593,000 | $4,660,000 |
| Current Debt | $0 | $4,200,000 | $4,463,000 | $4,660,000 |
| Liabilities | ||||
| Total Liabilities Net Minority Interest | $13,100,000 | $16,100,000 | $23,662,000 | $19,458,000 |
| Total Non Current Liabilities Net Minority Interest | $8,300,000 | $4,300,000 | $7,526,000 | $7,682,000 |
| Current Liabilities | $4,800,000 | $11,800,000 | $16,136,000 | $11,776,000 |
| Payables | $2,700,000 | $2,800,000 | $2,936,000 | $2,514,000 |
| Total Tax Payable | $100,000 | $200,000 | - | $139,000 |
| Accounts Payable | $2,600,000 | $2,600,000 | $2,936,000 | $2,459,000 |
| Other Current Liabilities | - | $100,000 | $10,000 | $12,000 |
| Other Payable | - | - | - | $55,000 |
| Other Non Current Liabilities | - | - | - | - |
| Equity | ||||
| Common Stock Equity | $-7,000,000 | $-9,000,000 | $6,967,000 | $30,607,000 |
| Total Equity Gross Minority Interest | $-7,000,000 | $-9,000,000 | $6,967,000 | $30,607,000 |
| Stockholders Equity | $-7,000,000 | $-9,000,000 | $6,967,000 | $30,607,000 |
| Other Equity Interest | $17,700,000 | $14,500,000 | - | $11,954,000 |
| Retained Earnings | $-165,100,000 | $-144,700,000 | $-178,325,000 | $-132,718,000 |
| Long Term Equity Investment | $0 | $0 | $0 | $9,000 |
| Investments In Other Ventures Under Equity Method | - | - | - | $9,000 |
| Other | ||||
| Ordinary Shares Number | $331,206,012 | $154,368,191 | $93,781,478 | $74,760,432 |
| Share Issued | $331,206,012 | $154,368,191 | $93,781,478 | $74,760,432 |
| Tangible Book Value | $-7,000,000 | $-9,000,000 | $6,967,000 | $30,607,000 |
| Invested Capital | $1,300,000 | $-500,000 | $18,915,000 | $42,949,000 |
| Working Capital | $1,000,000 | $-5,000,000 | $10,746,000 | $32,978,000 |
| Capital Lease Obligations | $0 | $0 | $171,000 | $0 |
| Total Capitalization | $1,300,000 | $-4,700,000 | $14,452,000 | $38,289,000 |
| Additional Paid In Capital | $141,300,000 | $121,800,000 | $186,456,000 | $164,012,000 |
| Capital Stock | $1,100,000 | $500,000 | $286,000 | $228,000 |
| Common Stock | $1,100,000 | $500,000 | $286,000 | $228,000 |
| Current Capital Lease Obligation | $0 | $0 | $130,000 | $0 |
| Investmentsin Subsidiariesat Cost | $0 | $0 | - | $0 |
| Net PPE | $200,000 | $200,000 | $1,186,000 | $1,369,000 |
| Accumulated Depreciation | $-300,000 | $-300,000 | $-850,000 | $-509,000 |
| Gross PPE | $500,000 | $500,000 | $2,036,000 | $1,878,000 |
| Other Properties | $200,000 | $200,000 | $1,142,000 | $1,143,000 |
| Machinery Furniture Equipment | $500,000 | $500,000 | $159,000 | $159,000 |
| Buildings And Improvements | $0 | $0 | $735,000 | $576,000 |
| Properties | $0 | $0 | $0 | $0 |
| Finished Goods | $200,000 | $300,000 | - | $1,160,000 |
| Other Short Term Investments | $100,000 | $700,000 | - | $2,744,000 |
| Treasury Shares Number | - | $0 | - | - |
| Long Term Capital Lease Obligation | - | $0 | $41,000 | $0 |
| Available For Sale Securities | - | $698,000 | $1,460,000 | $2,744,000 |
| Pensionand Other Post Retirement Benefit Plans Current | - | - | $3,866,000 | $1,437,000 |
| Investmentsin Joint Venturesat Cost | - | - | $0 | $9,000 |
| Construction In Progress | - | - | - | $0 |
Cash Flow Statement (Annual)
| Metric | 2025-06-30 | 2024-06-30 | 2023-06-30 | 2022-06-30 |
|---|---|---|---|---|
| Free Cash Flow | ||||
| Free Cash Flow | $-17,900,000 | $-29,800,000 | $-34,085,000 | $-46,586,000 |
| Operating Activities | ||||
| Operating Cash Flow | $-17,900,000 | $-29,800,000 | $-34,085,000 | $-45,924,000 |
| Investing Activities | ||||
| Investing Cash Flow | $0 | $100,000 | $0 | $-662,000 |
| Capital Expenditure | - | $-4,000 | - | $-662,000 |
| Net Other Investing Changes | - | - | - | - |
| Financing Activities | ||||
| Issuance Of Capital Stock | $19,500,000 | $11,900,000 | $20,557,000 | $9,210,000 |
| Financing Cash Flow | $16,000,000 | $10,000,000 | $16,386,000 | $25,630,000 |
| Net Common Stock Issuance | $19,500,000 | $11,900,000 | $20,557,000 | $9,210,000 |
| Common Stock Issuance | $19,500,000 | $11,900,000 | $20,557,000 | $9,210,000 |
| Other | ||||
| Repayment Of Debt | $-3,500,000 | $-1,700,000 | $-3,180,000 | $0 |
| End Cash Position | $3,600,000 | $4,700,000 | $24,682,000 | $41,333,000 |
| Beginning Cash Position | $4,700,000 | $24,700,000 | $41,333,000 | $65,128,000 |
| Effect Of Exchange Rate Changes | $800,000 | $-300,000 | $1,048,000 | $-2,839,000 |
| Changes In Cash | $-1,900,000 | $-19,700,000 | $-17,699,000 | $-20,956,000 |
| Net Issuance Payments Of Debt | $-3,500,000 | $-1,700,000 | $-3,180,000 | $18,020,000 |
| Net Long Term Debt Issuance | $-3,500,000 | $-1,700,000 | $-3,180,000 | $18,020,000 |
| Long Term Debt Payments | $-3,500,000 | $-1,700,000 | $-3,180,000 | $0 |
| Net Investment Purchase And Sale | $0 | $100,000 | - | $0 |
| Sale Of Investment | $0 | $100,000 | - | $0 |
| Net Business Purchase And Sale | $0 | $0 | - | $0 |
| Purchase Of Business | $0 | $0 | - | $0 |
| Change In Working Capital | $-3,300,000 | $-3,300,000 | $5,749,000 | $-192,000 |
| Change In Payable | $-2,700,000 | $-4,000,000 | $448,000 | $1,964,000 |
| Change In Prepaid Assets | $-800,000 | $200,000 | $1,299,000 | $-1,487,000 |
| Change In Inventory | $100,000 | $400,000 | - | $-807,000 |
| Change In Receivables | $100,000 | $100,000 | $125,000 | $-307,000 |
| Other Non Cash Items | $3,900,000 | $3,800,000 | $51,000 | $-4,117,000 |
| Stock Based Compensation | $3,200,000 | $1,100,000 | $2,932,000 | $4,621,000 |
| Depreciation And Amortization | $0 | $2,500,000 | $508,000 | $489,000 |
| Amortization Cash Flow | $0 | $2,300,000 | - | $2,309,000 |
| Gain Loss On Investment Securities | $500,000 | $600,000 | $3,281,000 | $5,900,000 |
| Net Foreign Currency Exchange Gain Loss | $-400,000 | $-200,000 | $-1,008,000 | $-7,340,000 |
| Net Income From Continuing Operations | $-21,800,000 | $-45,500,000 | $-45,607,000 | $-45,276,000 |
| Net PPE Purchase And Sale | - | $-4,000 | $0 | $-557,000 |
| Purchase Of PPE | - | $-4,000 | $0 | $-557,000 |
| Change In Other Current Assets | - | $0 | $29,000 | $-75,000 |
| Change In Accrued Expense | - | $-4,054,000 | $3,848,000 | $-234,000 |
| Depreciation | - | $200,000 | $508,000 | $489,000 |
| Issuance Of Debt | - | - | $0 | $18,020,000 |
| Long Term Debt Issuance | - | - | $0 | $18,020,000 |
| Net Intangibles Purchase And Sale | - | - | $0 | $-105,000 |
| Purchase Of Intangibles | - | - | $0 | $-105,000 |
| Change In Other Current Liabilities | - | - | $0 | $-53,000 |
| Gain Loss On Sale Of Business | - | - | $0 | $0 |
| Interest Received Cfi | - | - | - | $0 |
| Purchase Of Investment | - | - | - | $0 |
| Interest Received Cfo | - | - | - | - |